Step 1 topics → Neurology and Special Senses → Other Demyelinating Disorders (NMO, ADEM, PML, CPM)

Other Demyelinating Disorders (NMO, ADEM, PML, CPM)

USMLE Step 1 trap: Conflates NMO with MS rather than recognizing its distinct anti-AQP4 antibody mechanism. NMO is a distinct disease caused by anti-AQP4 (aquaporin-4) antibodies targeting astrocytes, not myelin oligodendrocyte glycoprotein as in MS.

These four demyelinating disorders — NMO, ADEM, PML, and CPM — show up on USMLE Step 1 as vignette-based differentiation problems. The exam won't just ask you to name them; it'll give you a clinical scenario and expect you to identify which disorder fits based on the trigger, population, mechanism, or lab finding. The core challenge is that students blur these together or lump them in with MS, which is a different disease category. Each disorder has a specific angle the exam hammers: NMO has its antibody, ADEM has its trigger and population, PML has its cause and risk group, and CPM has its prevention logic.

The trickiest part is that these disorders look superficially similar — they all involve white matter damage — but their mechanisms are completely different. NMO is antibody-mediated (anti-AQP4 targets astrocytes), ADEM is post-infectious immune dysregulation, PML is viral reactivation in the immunocompromised, and CPM is iatrogenic osmotic damage from correcting hyponatremia too fast. USMLE Step 1 exploits the temptation to call anything with white matter lesions 'MS-like.' Don't fall for it.

Expect vignettes where the diagnosis hinges on one or two key contextual clues: a child with new neuro deficits after a viral illness (ADEM), an HIV patient with progressive focal deficits and JC virus on PCR (PML), a patient who gets corrected from severe hyponatremia and then develops locked-in syndrome (CPM), or a patient with simultaneous optic neuritis and longitudinally extensive transverse myelitis with anti-AQP4 positive (NMO). The exam tests whether you can extract those anchor clues and match them to the right disorder.

From real student decks
86%have cards covering this topic
76%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: NMO is just a variant of MS with the same pathophysiology.
Right: NMO is a distinct disease caused by anti-AQP4 (aquaporin-4) antibodies targeting astrocytes, not myelin oligodendrocyte glycoprotein as in MS.
NMO and MS both cause demyelinating episodes, but their pathophysiology is fundamentally different. In MS, the immune attack is primarily directed at myelin and oligodendrocytes. In NMO, anti-AQP4 antibodies target aquaporin-4 water channels expressed on astrocyte end-feet, making it an astrocytopathy, not primarily a myelinopathy. This distinction matters clinically because NMO doesn't respond well to standard MS therapies and requires different immunosuppressive agents like rituximab or azathioprine.
Common mistake
Wrong: Osmotic demyelination syndrome (CPM) is caused by hyponatremia itself.
Right: CPM is caused by overly rapid correction of chronic hyponatremia, not by the hyponatremia itself.
It's not the low sodium itself that destroys pontine myelin — patients can be severely hyponatremic for days without developing CPM. The damage happens when chronic hyponatremia is corrected too quickly. The brain adapts to chronic low sodium by reducing intracellular osmoles; rapid correction creates a sudden osmotic gradient that pulls water out of neurons and triggers demyelination. The fix is slow correction (≤8–10 mEq/L per 24 hours), not avoiding treatment of hyponatremia.
Common mistake
Wrong: PML is caused by a new viral infection acquired in the immunocompromised state.
Right: PML is caused by reactivation of latent JC virus in severely immunocompromised patients, not a new primary infection.
Most adults have been exposed to JC virus during childhood with no consequence — it establishes latency in renal tubular cells and B cells. PML only develops when severe immunosuppression allows JC virus to reactivate and infect oligodendrocytes in the CNS. This is why PML appears in patients with late-stage HIV (CD4 <200), organ transplant recipients, or patients on natalizumab (which blocks lymphocyte trafficking into the CNS). It is not a newly acquired infection.
Common mistake
Wrong: ADEM and MS are distinguished only by lesion location, not by clinical context.
Right: ADEM is a monophasic post-infectious or post-vaccination demyelinating disease predominantly in children, whereas MS is relapsing-remitting and typically presents in young adults.
Both ADEM and MS cause multifocal demyelinating lesions, but their clinical context is completely different. ADEM is monophasic — it happens once, usually in children, 1–3 weeks after an infection or vaccination, and resolves (though with varying residual deficits). MS is a relapsing-remitting disease in young adults with no required infectious trigger. If a vignette describes a child with rapid-onset multifocal deficits after a recent illness, that's ADEM until proven otherwise — not MS.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the anti-AQP4 (aquaporin-4) antibody as the defining pathophysiologic marker of NMO, understand that it targets astrocytes (not myelin directly), and recognize the clinical picture of simultaneous or sequential optic neuritis plus longitudinally extensive transverse myelitis — and that steroids plus rituximab or other immunosuppressants are used in management.
  2. Recognize ADEM as a monophasic, post-infectious or post-vaccination demyelinating syndrome that predominantly affects children, presents with multifocal neurologic deficits, shows bilateral white matter lesions on MRI, and is treated with high-dose corticosteroids.
  3. Identify PML as reactivation of latent JC virus in severely immunocompromised patients (HIV/AIDS with low CD4, organ transplant recipients, natalizumab users), understand it has a poor prognosis, and know that MRI shows non-enhancing white matter lesions without mass effect.
  4. Understand that central pontine myelinolysis (osmotic demyelination syndrome) is triggered by overly rapid correction of chronic hyponatremia — not by the hyponatremia itself — and that it presents with quadriplegia, dysarthria, and dysphagia (locked-in syndrome pattern), preventable by correcting sodium at no more than 8–10 mEq/L per 24 hours.

Can you avoid these mistakes?

A 34-year-old woman presents with sudden vision loss in the right eye followed two weeks later by bilateral leg weakness and urinary retention. MRI shows a spinal cord lesion spanning more than three vertebral segments. Serum testing is ordered. What antibody confirms the diagnosis, and what cell type does it primarily target?
A 7-year-old boy develops confusion, ataxia, and right-sided weakness 10 days after recovering from chickenpox. MRI shows bilateral, asymmetric white matter lesions. What is the diagnosis, and how does it differ from MS in terms of clinical course and patient population?
A patient with HIV and a CD4 count of 45 develops progressive right-sided weakness and cognitive decline over 6 weeks. MRI shows non-enhancing white matter lesions without mass effect. CSF PCR is positive for JC virus. Why is this considered reactivation rather than primary infection, and what is the prognosis?
A 52-year-old with chronic alcoholism is admitted with a sodium of 108 mEq/L. Over the next 24 hours, sodium is corrected to 130 mEq/L. Three days later, he develops dysarthria, dysphagia, and quadriplegia. What is the diagnosis, what caused it, and what correction rate should have been used to prevent it?

Related topics

Neural Tube Formation and Derivatives Neural Crest Derivatives Neural Tube Defects Other Developmental Malformations

See how your Anki deck covers this topic.

Upload your deck for a free audit →